NASDAQ:ISPC

iSpecimen - ISPC Stock Forecast, Price & News

$1.65

-0.01 (-0.60%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.58
▼
$1.74
50-Day Range: $1.51
▼
$2.58
52-Week Range: $1.51
▼
$28.98

Volume: 117,146 shs
Average Volume: 970,470 shs
Market Capitalization: $14.65 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $12.13

iSpecimen MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 634.8% Upside
$12.13 Price Target
Short Interest: Healthy
1.93% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.36
Based on 11 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

308th out of 1,095 stocks

Commercial Physical Research Industry

7th out of 16 stocks

3.5

Analyst's Opinion

Consensus Rating
iSpecimen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $12.13, iSpecimen has a forecasted upside of 634.8% from its current price of $1.65.
Amount of Analyst Coverage
iSpecimen has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.93% of the float of iSpecimen has been sold short.
Short Interest Ratio / Days to Cover
iSpecimen has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in iSpecimen has recently decreased by 39.31%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
iSpecimen does not currently pay a dividend.
Dividend Growth
iSpecimen does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ISPC.

3.0

News and Social Media Coverage

News Sentiment
iSpecimen has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 11 news articles for iSpecimen this week, compared to 2 articles on an average week.
Search Interest
11 people have searched for ISPC on MarketBeat in the last 30 days. This is an increase of 267% compared to the previous 30 days.
MarketBeat Follows
3 people have added iSpecimen to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iSpecimen insiders have not sold or bought any company stock.
Percentage Held by Insiders
32.26% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 4.20% of the stock of iSpecimen is held by institutions.

0.6

Earnings and Valuation

Price to Book Value per Share Ratio
iSpecimen has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About iSpecimen

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

September 30, 2022 | bizjournals.com

Five things to know, and Worcester medical school that beat Harvard - Boston Business Journal - The Business Journals

September 29, 2022 | finance.yahoo.com

4Front Ventures and Pink Gene Foundation Launch National Breast Cancer Awareness Month Campaign - Yahoo Finance

September 29, 2022 | finance.yahoo.com

Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022 - Yahoo Finance

September 29, 2022 | bizjournals.com

The Petri Dish: iSpecimen's founding CEO, longtime COO depart

September 26, 2022 | benzinga.com

Benzinga Pinterest Rumors - How The Stock Reacts $PINS $PLNT $CCL $AGRI $ISPC Podcast - Benzinga

September 26, 2022 | benzinga.com

Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket - American Virtual Cl - Benzinga

September 26, 2022 | americanbankingnews.com

iSpecimen (NASDAQ:ISPC) Price Target Cut to $4.25 by Analysts at EF Hutton Acquisition Corp I

September 24, 2022 | seekingalpha.com

iSpecimen names finance chief Tracy Curley as interim CEO - Seeking Alpha

September 23, 2022 | nasdaq.com

Health Care Sector Update for 09/23/2022: ISPC,AADI,SONX - Nasdaq

September 23, 2022 | nasdaq.com

Health Care Sector Update for 09/23/2022: ATHX,ISPC,AADI,SONX - Nasdaq

September 22, 2022 | globenewswire.com

iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO - GlobeNewswire

September 22, 2022 | finance.yahoo.com

iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO

September 15, 2022 | reuters.com

ISPC.OQ - iSpecimen Inc | Stock Price & Latest News | Reuters

September 7, 2022 | benzinga.com

(ALNA), (BIAF) – 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

August 31, 2022 | streetinsider.com

iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 - StreetInsider.com

August 31, 2022 | finance.yahoo.com

iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

August 7, 2022 | finance.yahoo.com

iSpecimen Inc. (NASDAQ:ISPC) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

August 7, 2022 | nasdaq.com

iSpecimen Inc. (NASDAQ:ISPC) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Nasdaq

August 7, 2022 | finance.yahoo.com

iSpecimen Inc. (NASDAQ:ISPC) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

August 4, 2022 | investing.com

iSpecimen Inc. Misses Q2 EPS by 4c By Investing.com - Investing.com

August 4, 2022 | streetinsider.com

Form 8-K iSpecimen Inc. For: Aug 04 - StreetInsider.com

August 4, 2022 | finance.yahoo.com

iSpecimen Reports Second Quarter 2022 Financial and Operating Results - Yahoo Finance

August 4, 2022 | in.investing.com

iSpecimen Inc. Misses Q2 EPS by 4c By Investing.com - Investing.com India

August 4, 2022 | globenewswire.com

iSpecimen Reports Second Quarter 2022 Financial and Operating Results - GlobeNewswire

August 4, 2022 | globenewswire.com

iSpecimen Reports Second Quarter 2022 Financial and Operating Results - GlobeNewswire

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Company Calendar

Last Earnings: 8/04/2022
Today: 10/02/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ISPC
CUSIP: N/A
CIK: 1558569
Web: ispecimen.com
Phone: 781-301-6700
Fax: N/A
Employees: 59
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $12.13
High Stock Price Forecast: $20.00
Low Stock Price Forecast: $4.25
Forecasted Upside/Downside: +634.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,960,000.00
Net Margins: -84.89%
Pretax Margin: -84.89%
Return on Equity: -36.25%
Return on Assets: -29.38%

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 13.37
Quick Ratio: 13.37

Sales & Book Value

Annual Sales: $11.14 million
Price / Sales: 1.32
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.41 per share
Price / Book: 0.48

Miscellaneous

Outstanding Shares: 8,880,000
Free Float: 6,016,000
Market Cap: $14.65 million
Optionable: Not Optionable
Beta: 2.34

Key Executives

Dr. Christopher J. Ianelli M.D. (Age 54)
Ph.D., Founder, Pres, CEO & Director
Comp: $440k

Ms. Tracy Wilson Curley (Age 60)
CFO & Treasurer
Comp: $367k

Ms. Jill Mullan (Age 57)
COO, Sec. & Director
Comp: $391.25k

Mr. Benjamin Bielak (Age 52)
Chief Information Officer
Comp: $334k

Mr. Eric Langlois
Sr. VP of Sales & Bus. Devel.

Ms. Carly Lejnieks
VP of Marketing

Ms. Emily Hubbard
VP of Site Management & Devel.

Mr. David Wages M.D.
Ph.D., Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings or view top-rated stocks.
What is iSpecimen's stock price forecast for 2022?: 2 Wall Street research analysts have issued 12-month price targets for iSpecimen's shares. Their ISPC share price forecasts range from $4.25 to $20.00. On average, they predict the company's share price to reach $12.13 in the next year. This suggests a possible upside of 634.8% from the stock's current price.
View analysts price targets for ISPC or view top-rated stocks among Wall Street analysts.
How have ISPC shares performed in 2022?: iSpecimen's stock was trading at $7.81 at the start of the year. Since then, ISPC shares have decreased by 78.9% and is now trading at $1.65.
View the best growth stocks for 2022 here.
When is iSpecimen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ISPC earnings forecast.

How were iSpecimen's earnings last quarter?: iSpecimen Inc. (NASDAQ:ISPC) announced its earnings results on Thursday, August, 4th. The company reported ($0.30) EPS for the quarter. The business had revenue of $2.34 million for the quarter. iSpecimen had a negative trailing twelve-month return on equity of 36.25% and a negative net margin of 84.89%.
When did iSpecimen IPO?: (ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.
What is iSpecimen's stock symbol?: iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."
How do I buy shares of iSpecimen?: Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iSpecimen's stock price today?: One share of ISPC stock can currently be purchased for approximately $1.65.
How much money does iSpecimen make?: iSpecimen (NASDAQ:ISPC) has a market capitalization of $14.65 million and generates $11.14 million in revenue each year.
How can I contact iSpecimen?: The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

iSpecimen - ISPC Stock Forecast, Price & News

iSpecimen MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows